Literature DB >> 2432891

Sodium regulation of alpha 2-adrenoreceptors of human platelets: inactivation by 4,4'-diisothiocyano-2,2'-stilbene disulfonic acid (DIDS).

S M Periyasamy, P Somani.   

Abstract

In the present study, we investigated the effect of DIDS on Na+ regulation of alpha 2-adrenoreceptors in human platelets. Pretreatment of platelet membranes at 23 degrees C for 60 min with DIDS produced a reduction in the affinity of the receptors for both antagonist and agonist in a concentration related manner; however, there was a marked difference in the degree of reduction in the affinity of the receptors for antagonist and agonist. Thus, at 1 mM concentration of DIDS, the affinity of the receptors for antagonist was reduced by 2-fold while the affinity of the receptors for agonist was reduced by 14-fold. Furthermore, this concentration of DIDS abolished the ability of Na+ in reducing the affinity of the receptors for agonist. We suggest that the effect of DIDS is via Na+ binding component of the alpha 2-adrenoreceptor-adenylate cyclase complex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432891     DOI: 10.1016/s0006-291x(86)80357-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Anion channel blockers cause apparent inhibition of exocytosis by reacting with agonist or secretory product, not with cell.

Authors:  J G Vostal; D M Reid; C E Jones; N R Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  4,4'-Di-isothiocyanatostilbene-2,2'-disulphonic acid ('DIDS') activates protein kinase C and Na+/H+ exchange in human platelets via alpha 2A-adrenergic receptors.

Authors:  R Nieuwland; G Van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

3.  Effects of stilbenedisulfonic acid derivatives on the cAMP-regulated chloride current in cardiac myocytes.

Authors:  R D Harvey
Journal:  Pflugers Arch       Date:  1993-02       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.